THERAVANCE BIOPHARMA ANTIBIOTICS IP LLC has a total of 58 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in Brazil, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SHIRE BIOCHEM INC, VENTIRX PHARMACEUTICALS INC and ONCTERNAL THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 6 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | Hungary | 3 | |
#5 | Israel | 3 | |
#6 | Japan | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Mexico | 3 | |
#9 | Taiwan | 3 | |
#10 | South Africa | 3 | |
#11 | China | 2 | |
#12 | EAPO (Eurasian Patent Organization) | 2 | |
#13 | EPO (European Patent Office) | 2 | |
#14 | Georgia | 2 | |
#15 | Hong Kong | 2 | |
#16 | Republic of Moldova | 2 | |
#17 | Philippines | 2 | |
#18 | Singapore | 2 | |
#19 | Ukraine | 2 | |
#20 | United States | 2 | |
#21 | Argentina | 1 | |
#22 | Montenegro | 1 | |
#23 | Serbia | 1 | |
#24 | Tunisia | 1 | |
#25 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Nanostructure applications | |
#6 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lee Junning | 31 |
#2 | Zhang Weijiang | 28 |
#3 | Green Jack | 14 |
#4 | Filipov Dimitar | 14 |
#5 | Cheung Ronnie | 14 |
#6 | Tracey Michael R | 12 |
#7 | Junning Lee | 8 |
#8 | Barriere Steven L | 7 |
#9 | Lo Arthur | 7 |
#10 | Mammen Mathai | 7 |
Publication | Filing date | Title |
---|---|---|
WO2016137806A2 | Doses and methods of administering telavancin | |
AU2014249611A1 | Crystalline form of a substituted thiazolylacetic acid triethylamine salt |